You may now download this complete presentation for $5.99. Download with Paypal confidence at https://www.payloadz.com/go/sip?id=1583094 More marketing documents download at http://store.payloadz.com/results/results.asp?m=212023 Please contact me at hello@divyamishra.com for any questions regarding the download. Thanks Guys!

1. Case 30: Purinex,Inc. By: Divya Mishra

3. Option # 2

4. Option # 3Recommendation & Conclusion 2

5. Introduction 3

7. Commercialize therapeutic platform based on its purine drug development program4

9. Purinex intellectual portfolio consists of more than 35 patents pending or issued in the purine field5

11. Two drugs have applications for partnership deals with pharmaceutical companies for the treatment of diseases like diabetes and sepsis6

13. The drug used for the treatment of sepsis is in phase 2 of clinical trial 7

14. Drug Development Process (10-16 years) Discovery 2- 10 years Preclinical Testing Lab and animal testing Phase I 20-30 healthy volunteers used to check for safety & dosage Phase II 100-300 patient volunteers used to check for efficacy & side effects Phase III 1000-5000 patients volunteers used to monitor reactions to long term drug use FDA Review/Approval Extensive testing for drug safety Post Marketing 5%-10% drugs are approved for marketing 8

15. Situational Analysis & Key issue 9

17. Income from Federal Research Grant

18. Cash in hand- $700,000

19. Expenses - $60,000/month

20. Cash level would enable the company to survive for another 11 months only10

22. If the firm is capitalized ,there are better chances of securing a partnership11

24. Production Facilities

25. Co-promotion rights12

28. Agonist program for sepsis treatment14

30. Which deal is better for Purinex?“Sepsis deal or Diabetes deal ” 15

31. Option # 1 “Wait for 6 months” 16

33. Mutually exclusive contract for treatment, either one or the other

34. Company would be valued at $25 million17

37. Lower the value of the firm to $5 million18

38. Option #2 “Venture Capital Round” 19

40. $10 million

41. Short waiting time(3 months)20

43. Share earnings21

44. Option # 3 “Angel Round” 22

46. Provides 33 months survival23

48. Some restrictions like board appointment, share earnings24

49. Recommendation # 1 25

51. Recommendation # 2 27

54. It is ahead in the development process

55. Can provide Purinex with quicker milestones

56. Keep the right to the diabetes drug as it contains a higher revenue potential in the future29

57. 30